Pharmaceutical Technology-02-02-2004

The changing fundamentals of the industry are causing Big Pharma to focus more on operating efficiency instead of just product performance.

The author discusses why two of the industry's common practices for preventing microorganism contamination in USP hot-ware and purified-water systems may have no scientific basis.

FDA expands electronic data submission programs to improve regulatory operations and ensure appropriate and safe drug use.

Today's contract manufacturing organizations (CMOs) offer the latest in technology advanced equipment and innovative homegrown production processes.

The authors establish a quantitative framework for understanding the correlation between the segregation of pharmaceutical powders and various physical and process parameters.